Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raffaella Fittipaldi

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Comparative and Functional Genomics|June 16, 2012
Tackling skeletal muscle cells epigenome in the next-generation sequencing eraRaffaella Fittipaldi, Giuseppina Caretti
Genes & Development|June 12, 2013
The methyltransferase SMYD3 mediates the recruitment of transcriptional cofactors at the myostatin and c-Met genes and regulates skeletal muscle atrophyValentina Proserpio, Raffaella Fittipaldi, James G Ryall, et al.
Cells|June 2, 2021
The Lysine Methylase SMYD3 Modulates Mesendodermal Commitment during DevelopmentRaffaella Fittipaldi, Pamela Floris, Valentina Proserpio, et al.
Molecular Pharmaceutics|March 10, 2009
Novel cationic lipid that delivers siRNA and enhances therapeutic effect in lung cancer cellsYunching Chen, Joyeeta Sen, Surendar Reddy Bathula, et al.
Nature Communications|December 1, 2020
BETs inhibition attenuates oxidative stress and preserves muscle integrity in Duchenne muscular dystrophyMarco Segatto, Roberta Szokoll, Raffaella Fittipaldi, et al.
Nucleic Acids Research|December 14, 2018
SMYD3 promotes the epithelial-mesenchymal transition in breast cancerClaudio Fenizia, Cinzia Bottino, Silvia Corbetta, et al.
Oncotarget|April 21, 2017
Vitamin D and VDR in cancer cachexia and muscle regenerationAndrea Camperi, Fabrizio Pin, Domiziana Costamagna, et al.
Journal of Cellular Physiology|March 3, 2015
A SMYD3 Small-Molecule Inhibitor Impairing Cancer Cell GrowthAlessia Peserico, Aldo Germani, Paola Sanese, et al.
Nature Communications|November 24, 2017
Epigenetic targeting of bromodomain protein BRD4 counteracts cancer cachexia and prolongs survivalMarco Segatto, Raffaella Fittipaldi, Fabrizio Pin, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Comparative and Functional Genomics|June 16, 2012
Tackling skeletal muscle cells epigenome in the next-generation sequencing eraRaffaella Fittipaldi, Giuseppina Caretti
Genes & Development|June 12, 2013
The methyltransferase SMYD3 mediates the recruitment of transcriptional cofactors at the myostatin and c-Met genes and regulates skeletal muscle atrophyValentina Proserpio, Raffaella Fittipaldi, James G Ryall, et al.
Cells|June 2, 2021
The Lysine Methylase SMYD3 Modulates Mesendodermal Commitment during DevelopmentRaffaella Fittipaldi, Pamela Floris, Valentina Proserpio, et al.
Molecular Pharmaceutics|March 10, 2009
Novel cationic lipid that delivers siRNA and enhances therapeutic effect in lung cancer cellsYunching Chen, Joyeeta Sen, Surendar Reddy Bathula, et al.
Nature Communications|December 1, 2020
BETs inhibition attenuates oxidative stress and preserves muscle integrity in Duchenne muscular dystrophyMarco Segatto, Roberta Szokoll, Raffaella Fittipaldi, et al.
Nucleic Acids Research|December 14, 2018
SMYD3 promotes the epithelial-mesenchymal transition in breast cancerClaudio Fenizia, Cinzia Bottino, Silvia Corbetta, et al.
Oncotarget|April 21, 2017
Vitamin D and VDR in cancer cachexia and muscle regenerationAndrea Camperi, Fabrizio Pin, Domiziana Costamagna, et al.
Journal of Cellular Physiology|March 3, 2015
A SMYD3 Small-Molecule Inhibitor Impairing Cancer Cell GrowthAlessia Peserico, Aldo Germani, Paola Sanese, et al.
Nature Communications|November 24, 2017
Epigenetic targeting of bromodomain protein BRD4 counteracts cancer cachexia and prolongs survivalMarco Segatto, Raffaella Fittipaldi, Fabrizio Pin, et al.
Pageof 1